目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown

Chapter- 2: Summary and Highlights
Market Outlook
Market Summary

Chapter- 3: Market Overview
Introduction
Benefits of Outsourcing
Drawbacks to Outsourcing
Contract Manufacturing
Contract Research

Chapter- 4: Market Dynamics
Market Drivers
Market Restraints
Market Opportunities

Chapter- 5: Global Market for Biologics CDMOs by Product Type
Introduction
Biologics
Biosimilars

Chapter- 6: Global Market for Biologics CDMOs by Cell-Line Type
Mammalian
Microbial (Non-mammalian)
Other Modalities
Table 5 : Global Market for Biologics CDMOs, by Cell-Line Type, Through 2028
Figure 9 : Global Market for Biologics CDMOs, by Cell-Line Type, 2020-2028
Figure 10 : Global Market Shares of Biologics CDMOs, by Cell-Line Type, 2022

Chapter- 7: Global Market for Biologics CDMOs by Region
Market Overview and Discussion
North America
Europe
Asia-Pacific
RoW

Chapter- 8: Sustainability in Biologics CDMOs: An ESG Perspective
Introduction to ESG
Sustainability in Biologics CDMO Industry: An ESG Perspective

Chapter- 9: Emerging Technologies and Developments
Overview
Big Data, AI and ML
Single-use Technology
Process Analytical Technology (PAT)

Chapter- 10: Regulatory Landscape
Regulation of Biologics Services

Chapter- 11: M&A and Venture Funding Outlook
M&A Analysis
Recent News

Chapter- 12: Competitive Intelligence
Table 18 : Ranking of Biologics CDMOs

Chapter- 13: Company Profiles
ABBVIE PHARMACEUTICAL CONTRACT MANUFACTURING
AGC BIOLOGICS
BOEHRINGER INGELHEIM BIOXCELLENCE
BINEX CO. LTD.
BIOVIAN OY
BORA PHARMACEUTICAL CDMO
CATALENT INC
CYTOVANCE BIOLOGICS
EMERGENT BIOSERVICES
FUJIFILM DIOSYNTH BIOTECHNOLOGIES
ICON PLC
JRS PHARMA GMBH & CO. KG
KEMWELL
LONZA GROUP
LOTTE BIOLOGICS
PAREXEL INTERNATIONAL CORP.
RENTSCHLER BIOPHARMA SE
SAMSUNG BIOLOGICS
SANDOZ INTERNATIONAL GMBH
THERMO FISHER SCIENTIFIC INC.
TOYOBO CO. LTD.
WUXI XDC

Chapter- 14: Appendix
Table 49 : Acronyms